Yissum Research Development Company of The Hebrew University of Jerusalem

www.yissum.co.il

Technology Transfer Company

Tech Verticals Preferences

Agrifood, AgriTech, Artificial Intelligence, Big Data, Biotechnology, Chemistry, Climate Tech, Computer Vision, Cyber Security, Diagnostics, Digital Health, EdTech, Electro Optics, Energy Tech, Engineering, Environment, FoodTech, Healthtech, Machine Vision, Medical Cannabis, Medical Devices, MedTech, Microelectronics, Nanotechnology, Pharmaceuticals, Physics, Quantum Technology, Veterinary, WaterTech

General Data

Established	1964
Current Active Portfolio Companies:	119
Reg. Number:	abCDe

DESCRIPTION

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it was the 3rd company of its kind to be established, and has a rich tradition of innovation and commercialization. Through efforts to identify and create breakthrough scientific research at Hebrew University, Yissum aspires to advance commercial solutions to the most pressing global challenges facing humanity.

Yissum serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry organizations. Yissum’s expertise in innovation, collaboration, and operational excellence supports the commercialization of Hebrew University’s transformational and translational discoveries. Together with HU, it is creating beneficial applications in the fields of nanotechnology, the environment, pharmaceuticals, agriculture and nutrition, computer science and the humanities.

Since its inception, Yissum has registered close to 11,500 patents; has licensed over 1,100 technologies and has spun out over 245 diversified companies.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		Hebrew University of Jerusalem
	Accelerator	eClub HUJI	Hebrew University of Jerusalem
561C5192-509F-E611-9113-80C16E7D3630	Accelerator	BioGiv	Hebrew University of Jerusalem
91B73C66-937C-E511-BD22-80C16E7D3630	Accelerator	ASPER HUJI Innovate	Hebrew University of Jerusalem
DC829F8A-B0BD-E911-8106-0050569A1018	Accelerator	FaculTech	Hebrew University of Jerusalem
0D186F2F-231A-E311-924B-00237DE91982	Division	Biodesign Innovation Program of The Hebrew University of Jerusalem	Hebrew University of Jerusalem
8049693B-78CE-EE11-B812-00505695CD29	Investment Arm	MAAYAN Fund Management	Hebrew University of Jerusalem
86A5DB50-207A-E111-AC59-00155D32A403	Investment Arm	Yissum Research Development Company of The Hebrew University of Jerusalem	Hebrew University of Jerusalem
	Subsidiary	Gershon FinTech Center of the Hebrew University	Hebrew University of Jerusalem
	Subsidiary	Trans-disciplinary Innovation Program	Hebrew University of Jerusalem
C93F4F81-8CE4-F011-B81B-00505695CD29	Accelerator	Iris Accelerator	ASPER HUJI Innovate
317C8640-5957-E811-80E4-00155D0B832C	Accelerator	HuGrow	Yissum Research Development Company of The Hebrew University of Jerusalem	Ceased
3EAD6705-3910-EF11-B813-00505695CD29	Investment Arm	Rimon Philanthropic Investment Initiative	Yissum Research Development Company of The Hebrew University of Jerusalem
8101A492-98A5-E111-AD2F-00155D32A403	Investment Arm	Integra Holdings Ltd.	Yissum Research Development Company of The Hebrew University of Jerusalem
86313DA6-C0CB-E811-80F7-0050569A1018	Investment Arm	Racah Nano Venture	Yissum Research Development Company of The Hebrew University of Jerusalem
BDEFF543-8A53-E811-80E4-00155D0B832C	Investment Arm	Agrinnovation (Yissum) GP Ltd.	Yissum Research Development Company of The Hebrew University of Jerusalem

PARTNERS & SPONSORS

Company Name	Type	Partner/Sponsor
Universal Materials Incubator (UMI)	VC Fund	Partner

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Patent Attorneys

REMARKS

Date	Remark
25/11/2019	Yissum is in a strategic partnership with Universal Materials Incubator Ltd, a Japanese venture capital fund that focuses on chemicals and material sciences.
	Yissum founded Integra Holdings – a unique holding company that exclusively focuses on a selection of Yissum technologies and spinouts with proprietary solutions and a competitive advantage in their respective fields. Integra Holdings' portfolio is comprised of companies operating in the fields of cancer therapy, Alzheimer's disease, infectious diseases, inflammatory diseases and bipolar disorder.
	Yissum founded Agrinnovation in 2015, an investment partnership focused on nurturing agricultural inventions originating from The Hebrew University's Robert H. Smith Faculty of Agriculture Food and Environment. The partnership focuses on technologies relating to plant breeding and genetics, environmental technologies, plant protection, animal sciences, as well as veterinary and food technologies.

CONTACT INFO

Expand / Collapse All

Main Address: Jerusalem, Israel

Address	Hi-Tech Park, Edmond J. Safra Campus, Bungalow 2.6, Givat Ram
POB	39135
City	Jerusalem
Country	Israel
Zip	9139000

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Alon Natanson	CEO	Nonagon (CEO & President)
Mr. Sharon Shalom Cohen	CFO & COO	QLight (CFO)
Mr. Dan Fisher	General Counsel
Ms. Ariela Markel	SVP, Business Development, Healthcare	Ramot at TAU (VP BD, Healthcare)
Dr. Anat Iosub-Amir	VP, Business Development, Healthcare
Ms. Anna Pellivert	VP, Business Development, Physical Sciences, Computer & Social Sciences
Dr. Ilya Pittel	VP, Business Development, Agtech, Foodtech, Veterinary & Environmental Sciences
Mr. Barak Ben-Eliezer	Chairman
Mr. Amir Yavniely	Head of Innovation Lab for National Challenges
Mr. Yosef Haber	Director of Alliances and Portfolio Companies	Wristcam (Head of Operations)
Mr. Gady Paran	Director of Marketing
Ms. Tamar Gallily	Patent Attorney	Keryx (Patent Counsel)
Ms. Irina Abramzon-Shmueli	VP, Intellectual Property

	FINANCIAL ROUNDS

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Investment in Fund

May. 24, 2016

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2024

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Mar. 01, 2023

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Nov. 24, 2015

abCDe

Co-op with Applied Biomathematics Inc. (Setauket, NY).

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Bi-National Fund	abCDe

Investment Data

Preferences

Type of Financing	Equity,In-Licensing,Joint R&D
Stage Preferences	R&D,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Biomed

39%

Agritech

20%

Cleantech

13%

Medical Devices

Hardware & Industrial

Energy

Enterprise Software & Infrastructure

Semiconductors

Digital Health

Consumer-Oriented Software

	PORTFOLIO COMPANIES

Current Portfolio Companies (119)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

3BiotiX

Biomed

Seed

07/06/2023

N/A

$0.9m

Airovation

Cln.

Seed

01/05/2017

N/A

$0.85m

Akari

Biomed

Seed

01/06/2002

N/A

Ananda Labs

Biomed

Seed

01/01/2023

N/A

AquiNovo

Agri

Seed

08/10/2015

N/A

$0.75m

Ayana Pharma

Biomed

Seed

01/10/2011

N/A

BDUK

Biomed

Seed

01/02/2025

N/A

$4m

Betalin

Biomed

Seed

01/01/2015

N/A

$3m

Better Juice

Biomed

Seed

01/12/2017

N/A

$1m

Better Meal

HW & Indust.

Seed

01/01/2025

N/A

BeWeld

Seed

01/11/2021

N/A

$0.9m

BioArmix

Agri

Seed

01/01/2024

N/A

$0.9m

BioBetter

Biomed

Seed

16/09/2015

N/A

BNS

BioNanoSim (BNS) has developed a proprietary technology platform for the nano-encapsulation of drugs to improve delivery profile and therapeutic performance.

Research conducted by Professor Simon Benita and his team has demonstrated the potential of BNS's nano-encapsulation technology to design innovative routes of administration across a range of therapeutic areas including oncology, ophthalmology, and metabolic diseases. In addition, BNS is using its nano-encapsulation technologies to develop topical and ocular cannabis-based products.

Biomed

Seed

01/01/2015

N/A

$2m

CapsiBreed

Agri

Seed

01/12/2024

N/A

CardioVia

Seed - Extended

25/04/2018

N/A

Catalife

Cln.

Seed

01/12/2018

N/A

CaVos

Biomed

Seed

24/02/2022

N/A

$1m

CelluFlux

Energy

Seed

01/12/2019

N/A

ChickP

Agri

Seed

01/10/2016

N/A

$0.5m

Chiral Energy

Chiral operates in the field of advanced materials engineering and nanotechnology. The company develops materials and coatings that optimize electrochemical processes in batteries and electrolysis devices.

Energy

Seed

01/03/2022

N/A

Circuit Bio

Biomed

Seed

01/10/2020

N/A

$2.1m

Clairion

Cln.

Seed

01/01/2015

$0.03m

$0.5m

CogniFiber

Semicon.

Seed

30/01/2019

N/A

$2.5m

CollPlant

Biomed

Seed

01/06/2004

N/A

Cooling Crops

Agri

Seed

01/09/2024

N/A

CultivO2

Agri

Non-Equity Assistance

01/06/2024

N/A

Daika

Cln.

Seed

01/06/2020

N/A

$2.6m

Danziger Innovations

Founded in 1953, Danziger is one of the world’s innovative floriculture companies. The comapny is engaged in the research, breeding, development, propagation, production, sale and marketing of varieties of cut flowers, annuals and perennials – creating extraordinary flower varieties and beautiful assortments that help customers along the entire value chain achieve extraordinary success.

Agri

Seed

01/01/2008

N/A

ECS Cleantech

ECS specializes in sustainable environmental solutions, including wastewater treatment, biogas conversion and soil remediation. The company's innovative technologies ensure efficient, non-toxic and cost-effective contaminant removal.

Cln.

Seed

27/01/2025

N/A

Eden Materials

Cln.

Seed

01/10/2023

N/A

Emris Pharma

Biomed

Seed

01/01/2023

N/A

En Gibton

Cln.

Seed

01/06/2005

N/A

$0.46m

Everly Bio

EVerly is an operator of a computational biology process, intended for decision-support in fertility care. The company uses deep molecular data to develop standardized diagnostics, improve implementation success rates and identify novel potential biological interventions, empowering IVF clinics, fertility specialists and couples to make informed decisions, maximize success rates and minimize the emotional and financial toll associated with infertility treatments.

Dig. Health

Seed

23/02/2023

$0.1m

$1m

ExoNavis Therapeutics

Biomed

Seed

24/01/2022

N/A

Forsea

Agri

Seed

30/08/2021

N/A

$1m

Granalix

Agri

Seed

01/05/2013

N/A

Guide In Medical

Seed

01/06/2015

N/A

Heqa

Ent. SW

First Round	29/10/2020	N/A	N/A
Seed	01/10/2018	N/A	$0.9m

HighRad

Seed

01/01/2020

N/A

Hopec Pharma

Biomed

Seed

11/06/2023

N/A

HydroX

Energy

Seed

01/06/2015

N/A

$0.33m

Immunyx Pharma

Immunyx is intended to modulate neutrophil function to treat diseases. The company offers pioneering approaches to immune modulation by using targeted nanoparticles to change the function of neutrophils, enabling patients suffering from COPD, cancer and arthritis to avail of neutrophil treatments in order to cure the underlying pathologies.

Biomed

Seed

18/02/2021

N/A

$2.2m

Inland Ocean

Agri

Seed

01/07/2021

N/A

InnerEye

Ent. SW

Seed

01/01/2014

N/A

Integra Holdings

N/A

Investment in Fund

17/04/2012

N/A

$7m

Inteligels

Biomed

Seed

01/07/2020

N/A

$0.4m

Labs/02

N/A

Investment in Fund

15/03/2016

N/A

Labs/08

N/A

Investment in Fund

01/10/2019

N/A

LDS

Lyotropic Delivery Systems (LDS) is a nano and biotechnology company focusing on the development of novel liquid nano-sized delivery systems. LDS proprietary drug delivery systems enable solubiliztion of large loads of water-insoluble and poorly-permeable drug molecules as well as bio-macromolecules, while enhancing the drug transport across the membrane. LDS unique technology creates new indications for generic or innovative drugs, by using safe-to-use components, which are all categorized as GRAS (Generally Recognized As Safe) and/or are listed within the FDA Inactive Ingredient Guide data base (FDA IIG). LDS has broad intellectual property rights covering its drug delivery technologies. LDS Delivery Platform Technology Can Be Adapted for Various Administration Routes Including Dermal, Transdermal, Intravenous, Oral and Opthalmic Applications.

Biomed

Seed

01/02/2013

N/A

$3m

LipoCure

Biomed

Seed

01/03/2006

N/A

10/2011: The shares were transferred to Integra.

Lipomedix

Biomed

Seed

01/01/2012

N/A

MarineXcell

Agri

Seed

01/01/2023

N/A

MaxSum

Agri

Seed

01/03/2022

N/A

Meatologic

Agri

Seed

01/01/2023

N/A

Medium Well

Agri

Non-Equity Assistance

01/01/2022

N/A

MEDPNC

Dig. Health

Seed

01/03/2013

N/A

Melodea

Cln.

First Round

14/03/2013

N/A

$6m

Has signed a licensing agreement with Melodea.

Micro Ice (μIce)

HW & Indust.

Seed

01/11/2019

N/A

MYOR

Biomed

Seed

01/04/2018

N/A

$0.5m

Naya

Seed

01/03/2025

N/A

Nectin

Biomed

Seed

01/06/2017

N/A

$1m

Neteera

Seed

04/11/2016

N/A

$2m

Nexocarp

Cln.

Seed

01/02/2021

N/A

Noga3D

Cln.

Seed

24/02/2022

N/A

Novagali

Biomed

Seed

01/10/1997

N/A

$2m

Holds 10% of the company

Noxon

Biomed

Seed

01/02/2023

N/A

ODE Pharma

Biomed

Seed

02/11/2020

N/A

OphRx

Biomed

Seed

01/01/2015

N/A

$1m

Oraqon

Oragon develops highly sensitive quantum sensors that can be used in various industries and for military purposes.

HW & Indust.

Seed

01/11/2024

N/A

$10m

OrCam

Semicon.

Seed

01/04/2010

N/A

$5m

OrSight Pharma

Biomed

Seed

16/10/2023

N/A

Paulee CleanTec

Cln.

Seed

01/01/2008

N/A

Pepticom

Biomed

Seed

01/07/2011

N/A

Pepticore

Biomed

Seed

01/05/2024

N/A

Phat Foodtech

Agri

Seed

01/11/2023

N/A

Phenome Networks

Agri

Seed

01/03/2008

N/A

Pilpel Seeds

Agri

Seed

08/01/2020

N/A

Plantopia

Agri

Seed

01/01/2018

N/A

Plastic Back

Cln.

Seed

20/02/2020

N/A

Point6 Bio

Biomed

Seed

01/08/2022

N/A

$2.1m

Pre-Cure

Biomed

Seed

01/06/2023

N/A

Prevera

Cln.

Seed

23/09/2020

N/A

Primer’s Heritage Yeast

HW & Indust.

Non-Equity Assistance

01/10/2022

N/A

PsyRX

Biomed

Seed

09/11/2020

N/A

$2m

Qarakal

HW & Indust.

Seed

10/09/2024

N/A

QEDIT

Ent. SW

Seed

30/03/2017

N/A

$4m

Qedma

Ent. SW

Seed

20/10/2020

N/A

$4.67m

Raziel Therapeutics

Biomed

Seed

01/08/2012

N/A

$4m

ReadeRx

Biomed

Seed

01/03/2023

N/A

$2.1m

Remodeless CV

Seed

01/09/2019

N/A

Ripples

HW & Indust.

Seed

01/10/2013

N/A

RNAble

Biomed

Seed - Extended

24/01/2022

N/A

RNAWay

Agri

Seed

24/01/2022

N/A

RumaFeed

Agri

Seed

01/06/2020

N/A

Salignostics

Biomed

Seed

01/05/2016

N/A

Salion Energy

Energy

Seed

01/08/2024

N/A

Seevix

Biomed

Seed

01/03/2014

N/A

$3m

Senseera

Seed

02/12/2020

N/A

$0.5m

Sherman Diagnostics

Biomed

Seed

01/03/2020

N/A

Smart Resilin

Cln.

Seed

21/02/2019

N/A

SolCold

Cln.

Seed

01/01/2016

N/A

$0.1m

Solra

Energy

Seed

01/07/2021

N/A

Spero Biopharma

Biomed

Seed

01/06/2019

N/A

SpliSense

Biomed

Seed

01/11/2018

N/A

$1m

Sufresca

Agri

Seed

01/12/2019

N/A

$0.8m

Swift Duct

Seed

01/07/2020

N/A

$0.9m

Synovio

Biomed

Seed

01/02/2025

N/A

TensorQ

Ent. SW

Seed

01/12/2024

N/A

Tissue Dynamics

Biomed

Seed

01/01/2017

N/A

Togeder

CO SW

Seed

01/01/2025

N/A

TriEye

Semicon.

Seed

15/10/2017

N/A

$3m

UNI Therapeutics

Biomed

Seed

01/07/2022

N/A

ViroBlock

Biomed

Seed

01/10/2020

N/A

VitaLunga

Biomed

Seed

01/11/2018

N/A

ViVac

Biomed

Seed

01/12/2022

N/A

Voyager Medical

Seed

01/12/2015

N/A

Wilk

Agri

Seed

01/09/2020

N/A

$3.53m

Wonder Veggies

Agri

Seed

01/09/2022

N/A

Current VC Fund Portfolio (1)

Fund Name

Fund Type

Date Announced

Amount

Remarks

Racah Nano Venture...

Venture Capital Fund

01/07/2019

N/A

Exits (36)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	05/12/2019	abCDe
abC Defghij	IPO	30/11/2007	abCDe	04/2014: Delisted
abC Defghij	Acquired	30/11/2022	abCDe
abC Defghij	IPO	14/08/2006	abCDe	06/2019: Delisted from TASE following listing on NASDAQ.
abC Defghij	Acquired	03/10/2011	abCDe
abC Defghij	Acquired	09/05/2018	abCDe
abC Defghij	Acquired	26/11/2006	abCDe	In shares.
abC Defghij	Acquired	05/08/2021	abCDe
abC Defghij	IPO	16/07/2015	abCDe
abC Defghij	Holdings Sold		abCDe
abC Defghij	Acquired	05/12/2007	abCDe	$15m will be paid immediately, one third in cash and two-thirds in shares,; $17m will be paid subject to Ester meeting certain milestones.
abC Defghij	Holdings Sold		abCDe
abC Defghij	IPO	14/02/2010	abCDe
abC Defghij	Holdings Sold		abCDe
abC Defghij	Acquired	13/12/2018	abCDe
abC Defghij	IPO	28/07/2000	abCDe	08/04: Delisted from London AIM (KRX)
abC Defghij	Holdings Sold		abCDe
abC Defghij	Acquired	01/03/2009	abCDe	Acquired 51% of the company.
abC Defghij	Acquired	04/02/2025	abCDe
abC Defghij	Acquired	01/08/2001	abCDe
abC Defghij	Acquired	08/08/2017	abCDe
abC Defghij	IPO	01/08/2014	abCDe	Including Green Shoe Option ($132m).
abC Defghij	Holdings Sold		abCDe
abC Defghij	Acquired	01/06/2009	abCDe
abC Defghij	Merged	13/11/2003	abCDe
abC Defghij	IPO	01/01/1992	abCDe	6.11.2003: delisted from NASDAQ Europe (PHRM)
abC Defghij	Acquired	29/06/2015	abCDe
abC Defghij	Holdings Sold		abCDe
abC Defghij	IPO	25/11/2020	abCDe	Raised NIS $42.6m, post valuation of NIS $212.6m. Institutional investors only.
abC Defghij	IPO	22/12/2005	abCDe	08/2018: Delisted.
abC Defghij	Holdings Sold		abCDe
abC Defghij	Holdings Sold		abCDe
abC Defghij	Holdings Sold		abCDe
abC Defghij	Acquired	16/03/2010	abCDe
abC Defghij	Holdings Sold		abCDe
abC Defghij	Acquired	12/01/2017	abCDe	Acquired 56% of the company for $2m in cash and $1.8m in shares.

Historic Portfolio (77)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Aferrix

Ceased to Operate

Biomed

Seed

01/10/2002

N/A

$0.33m

Agrinnovation VC

N/A

Investment in Fund

21/10/2015

N/A

$6m

Algen

Ceased to Operate

Biomed

Other

01/11/2000

N/A

10/2011: The shares were transferred to Integra

Amendis

Suspendeed Operations

Seed

01/10/2010

N/A

Andlit Therapeutics

Ceased to Operate

Biomed

Seed

01/06/2019

N/A

AngioB

Ceased to Operate

Biomed

Other

01/06/2006

N/A

Apertio

Ceased to Operate

Ent. SW

Seed

01/10/2016

N/A

Ardia

Ceased to Operate

Dig. Health

Other

01/04/2000

N/A

Atox Bio

Ceased to Operate

Biomed

Seed

01/04/2003

N/A

10/2011: The shares were transferred to Integra.

Avraham Pharmaceuticals

Ceased to Operate

Biomed

Fourth Round	25/02/2016	N/A	$4m
Seed	14/04/2010	N/A	$9m

BacoCure

Ceased to Operate

Biomed

Seed

01/02/2018

N/A

Bactusense

Ceased to Operate

Biomed

Seed

01/05/2016

N/A

$0.55m

Believer Meats

Suspendeed Operations

Agri

Seed

02/05/2018

N/A

$2.2m

BioPass

Ceased to Operate

Seed

01/10/2021

N/A

Bountica

Ceased to Operate

Agri

Seed - Extended

24/01/2022

N/A

BrainWatch Tech

Ceased to Operate

Seed

01/01/2021

N/A

$0.9m

BreedIT

Ceased to Operate

Ent. SW

Seed

01/06/2013

N/A

CiiTech

Ceased to Operate

Biomed

Seed

01/09/2017

N/A

Compira

Ceased to Operate

Semicon.

Seed

01/11/2018

N/A

ConjuGate

Ceased to Operate

Biomed

Other

01/10/2005

N/A

CoolCite

Ceased to Operate

Ent. SW

Seed

01/04/2010

N/A

Crops Guard

Ceased to Operate

Agri

Seed

10/06/2020

N/A

Delivery Therapeutics Ltd.

Ceased to Operate

Other

01/10/2002

N/A

DigoPharm

Ceased to Operate

Biomed

Seed

01/04/2000

$0.1m

$0.2m

Dittekol

Ceased to Operate

Biomed

Other

01/04/2001

N/A

EggDetect

Ceased to Operate

Agri

Seed

01/08/2012

N/A

$3m

Epigenesis

Ceased to Operate

Biomed

Other

01/01/1997

N/A

Ficos

Ceased to Operate

HW & Indust.

Seed

01/01/2015

N/A

$0.47m

GemmaCert

Ceased to Operate

Agri

Seed

01/06/2016

N/A

$2m

Gene Vector Technologies

Ceased to Operate

Biomed

Other

01/04/2001

N/A

HIL Applied Medical

Ceased to Operate

Seed

24/11/2010

N/A

$0.9m

HumanEyes

Ceased to Operate

Ent. SW

Seed

01/01/2001

N/A

$1m

ImProDia

Suspendeed Operations

Biomed

Seed

01/06/2012

N/A

$0.5m

In-Ovo

Ceased to Operate

Agri

Seed

01/03/2004

N/A

I-Red Pharma

Ceased to Operate

Biomed

Seed

24/02/2022

N/A

Jexys

Suspendeed Operations

Biomed

Other

01/01/2000

N/A

Holds 20.7% of the company

Kinoko

Ceased to Operate

Agri

Seed

14/07/2020

N/A

Kiralis

Ceased to Operate

Cln.

Seed

01/06/2018

N/A

MacroBea

Ceased to Operate

Biomed

Seed

01/01/2011

N/A

MaimoniDex

Ceased to Operate

Biomed

Other

01/06/2002

N/A

MCFC

Ceased to Operate

Agri

Seed

12/09/2019

N/A

Metamind

Ceased to Operate

Biomed

Seed

01/06/2023

N/A

Morflora

Ceased to Operate

Agri

Seed

01/06/2009

N/A

$0.75m

MusicGenome

Suspendeed Operations

CO SW

Other

01/07/2000

N/A

MyComed

Ceased to Operate

Agri

Seed

24/01/2022

N/A

NanoAF

Suspendeed Operations

Biomed

Seed

01/05/2013

N/A

Nanolayers

Ceased to Operate

Semicon.

Other

01/10/2001

N/A

Nanolymf

Suspendeed Operations

Biomed

Other

01/10/2006

N/A

NanoSpine

Ceased to Operate

Biomed

Other

01/04/2002

N/A

NatSpears

Ceased to Operate

Biomed

Other

22/10/2002

N/A

Neoprol

Ceased to Operate

Biomed

Seed

01/01/2014

N/A

NewStem

Ceased to Operate

Biomed

Seed

01/09/2016

N/A

Novia Pharmaceuticals Ltd.

Ceased to Operate

Biomed

Seed

01/01/2001

N/A

NovoTyr

Ceased to Operate

Biomed

Other

01/03/2005

N/A

10/2011: The shares were transferred to Integra

NTT

Ceased to Operate

Biomed

Seed

01/02/2003

N/A

$0.32m

Omer Therapeutics

Ceased to Operate

Biomed

Other

05/05/2011

N/A

Optimos

Ceased to Operate

Network Infra.

Seed

01/04/2004

N/A

OxoN Medica Inc.

Ceased to Operate

Biomed

Seed

01/04/2000

N/A

PLR

Ceased to Operate

Biomed

Seed

01/08/2003

N/A

Quana

Suspendeed Operations

Biomed

Non-Equity Assistance

01/12/2017

N/A

Rav Galai

Suspendeed Operations

Agri

Seed

01/01/2001

N/A

Real Time Radiography

Ceased to Operate

HW & Indust.

Other

01/12/1998

N/A

Sea2Cell

Ceased to Operate

Cln.

Seed

18/10/2021

N/A

$0.87m

SensoGene

Ceased to Operate

Seed

01/10/2002

N/A

Sensotrade

Ceased to Operate

Ent. SW

Other

01/08/2010

N/A

Skinapp

Ceased to Operate

Dig. Health

Seed

01/07/2014

N/A

Stem Cell Therapeutics

Ceased to Operate

Biomed

Seed

01/10/2004

N/A

Target-In

Ceased to Operate

Biomed

Seed

01/03/2003

$0.2m

TheraVir

Ceased to Operate

Biomed

Seed

01/10/2001

N/A

$1.5m

Tiltan Pharma

Ceased to Operate

Biomed

Seed

01/02/2009

N/A

$2.5m

10/2011: The shares were transferred to Integra

TKsignal

Ceased to Operate

Biomed

Other

01/10/2002

N/A

Trellis Photonics

Ceased to Operate

Network Infra.

Other

01/01/1999

N/A

UnResto Ltd.

Ceased to Operate

Biomed

Seed

01/10/2000

N/A

Valensum

Ceased to Operate

Ent. SW

Other

01/01/2009

N/A

Valentis

Ceased to Operate

Agri

Seed

01/11/2013

N/A

$0.6m

VEGF Stimulation for...

Ceased to Operate

Biomed

Seed - Extended	01/01/2020	N/A	N/A
Seed	01/01/2019	N/A	N/A

Zion Medical

Ceased to Operate

Biomed

Seed

01/09/2014

N/A

Last Updated:	abCDe
IVC Number:	abCDe